Fig. 1From: Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysisPatient inclusion flowchart. Pooled data from a total of 240 lung cancer patients who received CBDCA+PEM or CBDCA+PTX were selected out of 2468 patients from two prospective observational studies and analyzedBack to article page